Workshop: A human pathway-based approach to disease and medicine
You are invited to attend a workshop titled “A Human Pathway-based Approach to Disease and Medicine” to be held June 26–27 in Bethesda, Md. The objective of this workshop, which also will be broadcast online, is to explore existing systems-biology projects and approaches and how these projects might be better coordinated to optimally improve disease understanding and interventions.
Despite investment of billions of dollars over the past few decades, development of new drugs and other potential disease interventions remains elusive and immensely expensive. There is a growing recognition that, to increase the drug-development success rate, a stronger focus on human-relevant data is needed. This data will support implementation of more relevant, efficient methods to understand chemical toxicity based on understanding and functionalizing human biological pathways.
A number of projects are underway internationally to mine literature, collect data, and develop these adverse outcome pathways. This workshop is intended to bring representatives from several of these projects to a single venue to identify barriers and opportunities and make recommendations regarding what is needed to achieve the goal of fully implementing a human systems-biology platform for understanding disease and improving interventions.
The workshop was organized by Chris Austin (NCATS/NIH), Brian Berridge (GSK), Warren Casey (NIEHS/NIH), Suzy Fitzpatrick (FDA), Robert Kavlock (EPA), Troy Seidle (HSI), Anton Simeonov (NCATS/NIH), Dan Tagle (NCATS/NIH) and Catherine Willett (HSUS/HSI).
To attend in person or view the webcast, please register HERE